Literature DB >> 30673917

TRAF6 regulates YAP signaling by promoting the ubiquitination and degradation of MST1 in pancreatic cancer.

Jian-Ang Li1, Tiantao Kuang2, Ning Pu1, Yuan Fang1, Xu Han1, Lei Zhang1, Xuefeng Xu1, Wenchuan Wu1, Dansong Wang2, Wenhui Lou1, Yefei Rong3.   

Abstract

TNF receptor-associated factor 6 (TRAF6), a regulator of NF-κB signaling, has been reported to be associated with the oncogenesis of various tumors including pancreatic cancer, but the underlying mechanisms remain unknown. Here, we found that knocking down the expression of TRAF6 impaired YAP signaling. Moreover, TRAF6 promoted the migration and colony formation of pancreatic cancer cells through YAP. Then, we found that TRAF6 interacted with and promoted the ubiquitination and degradation of MST1, and the expression of TRAF6 and MST1 was negatively correlated in primary human pancreatic cancer samples. Our results reveal that TRAF6 regulates YAP signaling by promoting the ubiquitination and degradation of MST1 in pancreatic cancer, suggesting that TRAF6 could be a possible E3 ligase of MST1 and a potential therapeutic target.

Entities:  

Keywords:  Hippo–YAP; MST1; NF-κB; Pancreatic cancer; TRAF6; Tumorigenicity; Ubiquitination

Mesh:

Substances:

Year:  2019        PMID: 30673917     DOI: 10.1007/s10238-018-00543-6

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  28 in total

1.  Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain.

Authors:  L Deng; C Wang; E Spencer; L Yang; A Braun; J You; C Slaughter; C Pickart; Z J Chen
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

2.  Mapping of MST1 kinase sites of phosphorylation. Activation and autophosphorylation.

Authors:  Helmut Glantschnig; Gideon A Rodan; Alfred A Reszka
Journal:  J Biol Chem       Date:  2002-09-09       Impact factor: 5.157

Review 3.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

4.  Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain.

Authors:  V Baud; Z G Liu; B Bennett; N Suzuki; Y Xia; M Karin
Journal:  Genes Dev       Date:  1999-05-15       Impact factor: 11.361

Review 5.  Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression.

Authors:  D S Bassères; A S Baldwin
Journal:  Oncogene       Date:  2006-10-30       Impact factor: 9.867

6.  Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression.

Authors:  Hai Song; Kinglun Kingston Mak; Lilia Topol; Kangsun Yun; Jianxin Hu; Lisa Garrett; Yongbin Chen; Ogyi Park; Jia Chang; R Mark Simpson; Cun-Yu Wang; Bin Gao; Jin Jiang; Yingzi Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-08       Impact factor: 11.205

7.  The E3 ligase TRAF6 regulates Akt ubiquitination and activation.

Authors:  Wei-Lei Yang; Jing Wang; Chia-Hsin Chan; Szu-Wei Lee; Alejandro D Campos; Betty Lamothe; Lana Hur; Brian C Grabiner; Xin Lin; Bryant G Darnay; Hui-Kuan Lin
Journal:  Science       Date:  2009-08-28       Impact factor: 47.728

8.  Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene.

Authors:  Dawang Zhou; Claudius Conrad; Fan Xia; Ji-Sun Park; Bernhard Payer; Yi Yin; Gregory Y Lauwers; Wolfgang Thasler; Jeannie T Lee; Joseph Avruch; Nabeel Bardeesy
Journal:  Cancer Cell       Date:  2009-11-06       Impact factor: 31.743

9.  Elucidation of a universal size-control mechanism in Drosophila and mammals.

Authors:  Jixin Dong; Georg Feldmann; Jianbin Huang; Shian Wu; Nailing Zhang; Sarah A Comerford; Mariana F Gayyed; Robert A Anders; Anirban Maitra; Duojia Pan
Journal:  Cell       Date:  2007-09-21       Impact factor: 41.582

10.  E2 interaction and dimerization in the crystal structure of TRAF6.

Authors:  Qian Yin; Su-Chang Lin; Betty Lamothe; Miao Lu; Yu-Chih Lo; Gregory Hura; Lixin Zheng; Rebecca L Rich; Alejandro D Campos; David G Myszka; Michael J Lenardo; Bryant G Darnay; Hao Wu
Journal:  Nat Struct Mol Biol       Date:  2009-05-24       Impact factor: 15.369

View more
  11 in total

1.  LncRNA SNHG17 knockdown promotes Parkin-dependent mitophagy and reduces apoptosis of podocytes through Mst1.

Authors:  Feng Guo; Weimin Wang; Yi Song; Lina Wu; Jiao Wang; Yanyan Zhao; Xiaojun Ma; Hongfei Ji; Yanling Liu; Zhizhen Li; Guijun Qin
Journal:  Cell Cycle       Date:  2020-07-05       Impact factor: 4.534

2.  Somatic nuclear auto-antigenic sperm protein sensitizes human breast cancer cells to 5-Fluorouracil.

Authors:  Yanjing Huang; Shenghui Yang; Weiling Yu; Ling Gui
Journal:  Cancer Chemother Pharmacol       Date:  2022-02-08       Impact factor: 3.333

3.  The Effects of TRAF6 on Growth and Progression in Colorectal Cancer are Regulated by miRNA-140.

Authors:  Guangwei Zhu; Zhibin Cheng; Chunlin Lin; Qin Wang; Yongjian Huang; Wei Zheng; Shugang Yang; Jianxin Ye
Journal:  Onco Targets Ther       Date:  2020-11-20       Impact factor: 4.147

4.  LOXL1-AS1 contributes to the proliferation and migration of laryngocarcinoma cells through miR-589-5p/TRAF6 axis.

Authors:  Guijun He; Wenfeng Yao; Liang Li; Yang Wu; Guojian Feng; Li Chen
Journal:  Cancer Cell Int       Date:  2020-10-13       Impact factor: 5.722

5.  MST1 inhibits the progression of breast cancer by regulating the Hippo signaling pathway and may serve as a prognostic biomarker.

Authors:  Xiang Jin; Lihua Zhu; Sheng Xiao; Zhuhong Cui; Jing Tang; Jiangyong Yu; Mingjun Xie
Journal:  Mol Med Rep       Date:  2021-03-24       Impact factor: 2.952

6.  The concentration of tumor necrosis factor-α determines its protective or damaging effect on liver injury by regulating Yap activity.

Authors:  Shanmin Zhao; Jinghua Jiang; Yingying Jing; Wenting Liu; Xue Yang; Xiaojuan Hou; Lu Gao; Lixin Wei
Journal:  Cell Death Dis       Date:  2020-01-27       Impact factor: 8.469

7.  ALKBH5 suppresses tumor progression via an m6A-dependent epigenetic silencing of pre-miR-181b-1/YAP signaling axis in osteosarcoma.

Authors:  Ye Yuan; Gege Yan; Mingyu He; Hong Lei; Linqiang Li; Yang Wang; Xiaoqi He; Guanghui Li; Quan Wang; Yuelin Gao; Zhezhe Qu; Zhongting Mei; Zhihua Shen; Jiaying Pu; Ao Wang; Wei Zhao; Huiwei Jiang; Weijie Du; Lei Yang
Journal:  Cell Death Dis       Date:  2021-01-11       Impact factor: 8.469

8.  RNF6 promotes the migration and invasion of breast cancer by promoting the ubiquitination and degradation of MST1.

Authors:  Yajuan Huang; Yufeng Zou; Zhigang Jie
Journal:  Exp Ther Med       Date:  2021-12-06       Impact factor: 2.751

Review 9.  Impact of posttranslational modifications in pancreatic carcinogenesis and treatments.

Authors:  Nianhong Chen; Qiaoqiao Zheng; Guoqing Wan; Feng Guo; Xiaobin Zeng; Ping Shi
Journal:  Cancer Metastasis Rev       Date:  2021-08-03       Impact factor: 9.264

10.  Mammalian STE20‑like kinase 1 regulates pancreatic cancer cell survival and migration through Mfn2‑mediated mitophagy.

Authors:  Yongli Hu; Bing Wang; Lie Wang; Zhenran Wang; Zhiyuan Jian; Lin Deng
Journal:  Mol Med Rep       Date:  2020-04-28       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.